T1	Outcomes 794 811	serum MDA and SOD
T2	Outcomes 888 937	blood pressure, lipids and hepatic/renal function
T3	Outcomes 1026 1039	levels of MDA
T4	Outcomes 1054 1109	hypertension patient groups were higher, SOD was lower.
T5	Outcomes 1141 1193	decreased serum MDA levels but increased SOD content
T6	Outcomes 1199 1243	probucol treatment exaggerated these effects
T7	Outcomes 1250 1287	greater reduction of serum MDA levels
T8	Outcomes 1292 1324	greater increase of SOD content.
T9	Outcomes 1368 1417	improve oxidative stress in hypertension patients
T10	Outcomes 1432 1456	reduced serum MDA levels
T11	Outcomes 1461 1482	improved SOD activity
T12	Outcomes 1511 1535	antihypertensive effect.
